Mealey's (February 19, 2021, 12:52 PM EST) -- WASHINGTON, D.C. — In a Feb. 18 ruling, the Federal Circuit U.S. Court of Appeals said the Patent Trial and Appeal Board erred in confirming as patentable two independent claims of a patented skin cancer detection, diagnosis and treatment device....